Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Calcium Trimetaphosphate
2. Magnesium Trimetaphosphate
3. Trimetaphosphoric Acid
4. Trimetaphosphoric Acid, 99tc-labeled Cpd
5. Trimetaphosphoric Acid, Calcium (2:3) Salt, Hexahydrate
6. Trimetaphosphoric Acid, Magnesium (2:3) Salt
7. Trimetaphosphoric Acid, Magnesium (2:3) Salt, Dodecahydrate
8. Trimetaphosphoric Acid, Ruthenium (+3) Salt
9. Trimetaphosphoric Acid, Tripotassium Salt
10. Trimetaphosphoric Acid, Trisodium Salt
1. 7785-84-4
2. Trisodium Trimetaphosphate
3. Sodium Trimetaphosphate [usan]
4. 3ih6169rl0
5. Cyclicsodiumtrimetaphosphate
6. Trisodium;2,4,6-trioxido-1,3,5,2lambda5,4lambda5,6lambda5-trioxatriphosphinane 2,4,6-trioxide
7. Sodium Trimetaphosphate (usan)
8. Trisodium Metaphosphate
9. Polyrinsan 58
10. Cyclic Sodium Trimetaphosphate
11. Sodium Phosphate ((napo3)3)
12. Hsdb 5048
13. Metaphosphoric Acid, Trisodium Salt
14. Sodium Metaphosphate (na3(p3o9))
15. Einecs 232-088-3
16. Trisodium Trimetaphosphate (na3p3o9)
17. Cyclisches Trinatriummetaphosphat [german]
18. Unii-3ih6169rl0
19. Ccris 8524
20. Cyclisches Trinatriummetaphosphat
21. Metaphosphoric Acid (h3p3o9), Trisodium Salt
22. Trimetaphosphoric Acid (h3p3o9), Trisodium Salt
23. 1,3,5,2,4,6-trioxatriphosphorinane, 2,4,6-trihydroxy-, Trisodium Salt
24. Ec 232-088-3
25. Chembl2107557
26. Dtxsid7052789
27. Trimetaphosphate Grade Iii Trisodium
28. Sodium Trimetaphosphate [ii]
29. Sodium Trimetaphosphate [mi]
30. Mfcd00867826
31. Sodium Trimetaphosphate [fcc]
32. Sodium Trimetaphosphate [hsdb]
33. Sodium Trimetaphosphate [inci]
34. Sodium Trimetaphosphate [vandf]
35. D02423
36. E75943
37. Metaphosphoric Acid (h3p3o9), Sodium Salt (1:3)
38. Q7553388
39. (triphosphoric Acid Alpha,beta,gamma-trisodium)alpha,gamma-anhydride Salt
40. 2,4,6-tris(sodiooxy)-1,3,5,2,4,6-trioxatriphosphorinane 2,4,6-trioxide
| Molecular Weight | 305.89 g/mol |
|---|---|
| Molecular Formula | Na3O9P3 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 0 |
| Exact Mass | 305.84482541 g/mol |
| Monoisotopic Mass | 305.84482541 g/mol |
| Topological Polar Surface Area | 148 Ų |
| Heavy Atom Count | 15 |
| Formal Charge | 0 |
| Complexity | 224 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 4 |
Cariostatic Agents
National Library of Medicine's Medical Subject Headings online file (MeSH, 1999)
EXPTL USE: A 3-YR STUDY ON SCHOOL-AGE CHILDREN USING SODIUM TRIMETAPHOSPHATE AS A CHEWING GUM ADDITIVE PRODUCED REDUCTIONS IN PROXIMAL SURFACE DENTAL CARIES INCREMENTS AS COMPARED TO A NONCHEWING GUM GROUP. THE REDUCTIONS WERE 23.3% FOR THE SODIUM TRIMETAPHOSPHATE SUCROSE GUM GROUP & 47.6% FOR THE SODIUM TRIMETAPHOSPHATE NONSUGAR GROUP AS COMPARED TO THE NO-GUM GROUP. ... A MARGINAL EFFECT ON OVERALL CARIES INCREMENTS CAN BE ASCRIBED TO THE AGENT. THIS OVERALL EFFECT RESULTED FROM A SIGNIFICANT REDUCTION OF CARIES ON THE PROXIMAL SURFACES OF TEETH, ALTHOUGH OTHER SURFACES WERE NOT AS PROTECTED. ... THE LEVEL OF PROTECTION PROVIDED BY SODIUM TRIMETAPHOSPHATE IN THIS STUDY, OR BY DIETARY PHOSPHATES IN GENERAL, APPEARS SMALL RELATIVE TO OTHER CARIES-PREVENTING AGENTS, SUCH AS TOPICAL FLUORIDES.
PMID:273637 FINN SB ET AL; J AM DENT ASSOC 96 (4): 651-5 (1978)
SODIUM TRIMETAPHOSPHATE ADDED TO CHEWING GUM IS OF MARGINAL VALUE IN REDUCING DENTAL CARIES ON PROXIMAL SURFACES OF PERMANENT TEETH.
FINN SB ET AL; US NTIS PB REP ISS PB-273581 1-70 (1976)
Cariostatic Agents
Substances that inhibit or arrest DENTAL CARIES formation. (Boucher's Clinical Dental Terminology, 4th ed) (See all compounds classified as Cariostatic Agents.)
... LITTLE, IF ANY, CYCLIC METAPHOSPHATE IS ABSORBED THRU INTESTINAL WALL WHEN ADMIN ORALLY. THE METAPHOSPHATES MUST FIRST BE HYDROLYZED TO TRIPOLYPHOSPHATE & NEXT TO ORTHOPHOSPHATE, WHICH THEN CAN BE ABSORBED.
Furia, T.E. (ed.). CRC Handbook of Food Additives. 2nd ed. Cleveland: The Chemical Rubber Co., 1972., p. 642
Condensed phosphates (CP) used as food additives depressed the growth of 7 strains of Streptococcus mutans (serotype a-g) as assessed by disk diffusion methods. Minimal inhibitory concn (MIC) of condensed phosphates on Streptococcus mutans appeared to be related to their chelating capacity. The antibacterial action of condensed phosphates seemed largely bacteriostatic. Condensed phosphates depressed lactate production from glucose and sucrose by the cells of strain Kl-R. Condensed phosphates depressed insoluble glucan production from sucrose by the cells of Kl-R. The inhibition of sugar metabolism may be due to the interference of sugar transport into Streptococcus mutans induced by the chelation effects of condensed phosphates. Hamsters were inoculated orally with strain Kl-R and reared on the high-sucrose diet No 2000 supplemented with 2% (wt/wt) condensed phosphates for 60 days. Dietary supplements of condensed phosphates were associated with reduced caries activity and plaque formation.
PMID:6961893 Shibata H, Morioka T; Arch Oral Biol 27 (10): 809-16 (1982)
ABOUT THIS PAGE
A Trimetaphosphoric Acid manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Trimetaphosphoric Acid, including repackagers and relabelers. The FDA regulates Trimetaphosphoric Acid manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Trimetaphosphoric Acid API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Trimetaphosphoric Acid supplier is an individual or a company that provides Trimetaphosphoric Acid active pharmaceutical ingredient (API) or Trimetaphosphoric Acid finished formulations upon request. The Trimetaphosphoric Acid suppliers may include Trimetaphosphoric Acid API manufacturers, exporters, distributors and traders.
click here to find a list of Trimetaphosphoric Acid suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Trimetaphosphoric Acid DMF (Drug Master File) is a document detailing the whole manufacturing process of Trimetaphosphoric Acid active pharmaceutical ingredient (API) in detail. Different forms of Trimetaphosphoric Acid DMFs exist exist since differing nations have different regulations, such as Trimetaphosphoric Acid USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Trimetaphosphoric Acid DMF submitted to regulatory agencies in the US is known as a USDMF. Trimetaphosphoric Acid USDMF includes data on Trimetaphosphoric Acid's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Trimetaphosphoric Acid USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Trimetaphosphoric Acid suppliers with USDMF on PharmaCompass.
Trimetaphosphoric Acid Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Trimetaphosphoric Acid GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Trimetaphosphoric Acid GMP manufacturer or Trimetaphosphoric Acid GMP API supplier for your needs.
A Trimetaphosphoric Acid CoA (Certificate of Analysis) is a formal document that attests to Trimetaphosphoric Acid's compliance with Trimetaphosphoric Acid specifications and serves as a tool for batch-level quality control.
Trimetaphosphoric Acid CoA mostly includes findings from lab analyses of a specific batch. For each Trimetaphosphoric Acid CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Trimetaphosphoric Acid may be tested according to a variety of international standards, such as European Pharmacopoeia (Trimetaphosphoric Acid EP), Trimetaphosphoric Acid JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Trimetaphosphoric Acid USP).
LOOKING FOR A SUPPLIER?
